Change of transferrin sialylation differs between mild sepsis and severe sepsis and septic shock

Internal Medicine

Volumn 50, Issue 8, 2011, Pages 861-869

  Gornik, Olga ^a   Gornik, Ivan ^b   Kolednjak, Ivana Zagorec ^a   Lauc, Gordan ^a,c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

Author keywords

Iron metabolism; Protein sialylation; Sepsis; Severity of sepsis; Transferrin sialylation

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MALE; PILOT STUDY; PROTEIN GLYCOSYLATION; SEPTIC SHOCK; SIALYLATION; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PROTEINS; C-REACTIVE PROTEIN; FEMALE; FERRITINS; GLYCOSYLATION; HUMANS; IRON; MALE; MIDDLE AGED; PILOT PROJECTS; SEPSIS; SHOCK, SEPTIC; SIALIC ACIDS; TIME FACTORS; TRANSFERRIN;

EID: 79955563481     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4704     Document Type: Article

References (44)

1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530-538, 2003.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874, 1992.
3. Cinel I, Dellinger RP. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20: 345-352, 2007.
4. Esper AM, Martin GS. Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 13: 120, 2009.
5. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 10: R42, 2006.
6. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30: 536-555, 2004.
7. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34: 17-60, 2008.
8. Marshall JC. The pathogenesis and molecular biology of sepsis. Crit Care Resusc 8: 227-229, 2006.
9. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37: 291-304, 2009.
10. Remick DG. Applied molecular biology of sepsis. J Crit Care 10: 198-212, 1995.
11. Hayashi S, Gillam IC, Bondy G, Duronio V, Hogg JC. Molecular mechanisms of sepsis: molecular biology of the cell. J Crit Care 10: 82-95, 1995.
12. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 190: 1-46, 1990.
13. Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A. Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 264: 2415-2423, 1989.
14. Sturiale L, Barone R, Fiumara A, et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin Nglycans in untreated galactosemia. Glycobiology 15: 1268-1276, 2005.
15. Edwards M, McKenzie F, O'Callaghan S, et al. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops. Prenat Diagn 26: 985-988, 2006.
16. Arndt T, Hackler R, Muller T, Kleine TO, Gressner AM. Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation. Clin Chem 43: 344-351, 1997.
17. Grzymislawski M, Derc K, Sobieska M, Wiktorowicz K. Microheterogeneity of acute phase proteins in patients with ulcerative colitis. World J Gastroenterol 12: 5191-5195, 2006.
18. Gornik O, Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25: 267-278, 2008.
19. Gornik O, Lauc G. Enzyme linked lectin assay (ELLA) for direct analysis of transferrin sialylation in serum samples. Clin Biochem 40: 718-723, 2007.
20. Piagnerelli M, Boudjeltia KZ, Nuyens V, et al. Rapid alterations in transferrin sialylation during sepsis. Shock 24: 48-52, 2005.
21. van Haga PR. Microdetermination of serum iron and of ironbinding capacity by precision photometry. Mikrochim Acta 542-547, 1976.
22. Cynober L, Le Boucher J, Giboudeau J. Immunoturbidimetric determination of serum transferrin on a Kone Progress autoanalyser. J Automat Chem 11: 40-41, 1989.
23. Svennerholm L. On the isolation and characterization of N-acetylsialic acid. Acta Soc Med Ups 61: 74-85, 1956.
24. Svennerholm L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24: 604-611, 1957.
25. Martensson E, Raal A, Svennerholm L. Sialic acids in blood serum. Biochim Biophys Acta 30: 124-129, 1958.
26. Gornik O, Gornik I, Gasparovic V, Lauc G. Change in transferrin sialylation is a potential prognostic marker for severity of acute pancreatitis. Clin Biochem 41: 504-510, 2008.
27. von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 27: 2630-2639, 1999.
28. Bobbio-Pallavicini F, Verde G, Spriano P, et al. Body iron status in critically ill patients: significance of serum ferritin. Intensive Care Med 15: 171-178, 1989.
29. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16: 36-41, 2001.
30. Wizorek JJ, Turnbull IR, Buchman TG. Iron overload before cecal ligation and puncture increases mortality. Shock 20: 52-55, 2003.
31. Piagnerelli M, Vincent JL. Role of iron in anaemic critically ill patients: it's time to investigate! Crit Care 8: 306-307, 2004.
32. Rudolph JR, Regoeczi E, Chindemi PA, Debanne MT. Preferential hepatic uptake of iron from rat asialotransferrin: possible engagement of two receptors. Am J Physiol 251: G398-G404, 1986.
33. Beguin Y, Bergamaschi G, Huebers HA, Finch CA. The behavior of asialotransferrin-iron in the rat. Am J Hematol 29: 204-210, 1988.
34. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37: 2029-2037, 1991.
35. Piagnerelli M, Boudjeltia KZ, Rapotec A, et al. Neuraminidase alters red blood cells in sepsis. Crit Care Med 37: 1244-1250, 2009.
36. Stamatos NM, Liang F, Nan X, et al. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. FEBS J 272: 2545-2556, 2005.
37. Liang F, Seyrantepe V, Landry K, et al. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. J Biol Chem 281: 27526-27538, 2006.
38. Nan X, Carubelli I, Stamatos NM. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma. J Leukoc Biol 81: 284-296, 2007.
39. Seyrantepe V, Iannello A, Liang F, et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem 285: 206-215, 2010.
40. Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, Lauc G. Stability of N-glycan profiles in human plasma. Glycobiology 19: 1547-1553, 2009.
41. Darveau M, Denault AY, Blais N, Notebaert E. Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 8: 356-362, 2004.
42. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 70: 7-12, 1999.
43. Sears DA. Anemia of chronic disease. Med Clin North Am 76: 567-579, 1992.
44. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 25: 888-895, 1997.